Seer (SEER) Other Accumulated Expenses (2022 - 2026)
Seer (SEER) recorded quarterly Other Accumulated Expenses of $38000.0 in Q1 2026, up 31.03% quarter-over-quarter from $29000.0 in Q4 2025, and down 7.32% on a YoY basis from $41000.0 in Q1 2025.
Seer (SEER) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
Seer's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $38000.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 7.32% year-over-year to $38000.0; the TTM figure through Mar 2026 stood at $38000.0 (down 7.32% YoY), while the FY2025 annual figure was $29000.0, down 42.0% from the prior year.
- Other Accumulated Expenses was $38000.0 for Q1 2026 at Seer, up from $29000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $207000.0 in Q4 2022 to a low of $18000.0 in Q3 2025.
- Historically, Other Accumulated Expenses has averaged $110812.5 across 5 years, with a median of $131000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses grew 17.89% in 2024, then tumbled 87.59% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $207000.0 in 2022, then plunged by 32.85% to $139000.0 in 2023, then sank by 64.03% to $50000.0 in 2024, then slumped by 42.0% to $29000.0 in 2025, then surged by 31.03% to $38000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $38000.0 (Q1 2026), $29000.0 (Q4 2025), and $18000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Dec 31, 2023 | 139,000.00 |
| Sep 30, 2023 | 123,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | 172,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 181,000.00 |
| Jun 30, 2022 | 197,000.00 |